| URN | urn:agi-cas:53-57-6 |
|---|---|
| Total Entities | 9 |
| Connectivity | 1713 |
| Name | NADPH |
| ChildConcepts | NADH |
|---|---|
| NAD+ | |
| NADP+ | |
| carba-NAD | |
| Deaminocozymase | |
| 3-Apadn | |
| NFDH | |
| 3'-phospho-ADP | |
| 2'-Deoxy NAD |
| Pathway | Neurotoxin-Induced Parkinson's Disease |
|---|---|
| Role of Polyol Pathway in Diabetic Microangiopathy | |
| Peripheral Tissue Microangiopathy in Insulin Resistance | |
| Pancreatic Beta-cell Death in Diabetes Mellitus Type 2 | |
| Defective Clearance of Apoptotic Keratinocytes in Systemic Lupus Erythematosus | |
| Hemoglobin Reduction and Leukocyte Adhesion Initiate Vasospasm | |
| CFTR Up-regulates the Oxidative Stress in Airway Epithelium in Cystic Fibrosis | |
| Diabetes-Induced Cataract | |
| Age-Related Cataract | |
| Tricarboxylic acid cycle | |
| Pentose-phosphate shunt | |
| Mannose metabolism | |
| Serine and Glycine metabolism | |
| Tryptophan metabolism | |
| Phenylalanine and Tyrosine metabolism | |
| Ser/Gly/Thr/Cys metabolism | |
| Lysine metabolsm | |
| Urea cycle and arginine metabolism | |
| Glu/Gln/Pro metabolsm | |
| Methionine metabolism | |
| Purine metabolism | |
| Pyrimidine metabolism | |
| Nicotinate and nicotinamide metabolism | |
| Pterine biosynthesis | |
| Folate biosynthesis | |
| Heme oxidation | |
| Bile acids metabolism | |
| Biosynthesis of cholesterol | |
| Metabolism of glucocorticoids and mineralcorticoids | |
| Metabolism of estrogens and androgens | |
| Arachidonic acid metabolism | |
| Metabolism of triacylglycerols | |
| Sphingolipid metabolism | |
| ROS metabolism | |
| Fatty acid oxidation | |
| Metabolism of glycerophospholipids and ether lipids | |
| Fatty acid biosynthesis | |
| Bile acid metabolism (alternative pathway) | |
| Galactose metabolism | |
| Ascorbate biosyntesis | |
| Pyruvate metabolism | |
| L-sugars oxidation | |
| Vitamin A (retinol) metabolism and visual cycle | |
| Glutathione metabolism | |
| Malonate, propanoate and beta-alanine metabolism | |
| Riboflavin metabolism | |
| Caffeine metabolism | |
| Selencompound biosynthesis | |
| Ethanol metabolism | |
| Omega-3-fatty acid metabolism | |
| Glyoxylate and glycerate metabolism | |
| D-amino acid metabolism | |
| Mevalonate pathway | |
| Omega-6-fatty acid metabolism | |
| Ubiquinoine biosynthesis | |
| Ubiquinoine biosynthesis in humans | |
| Ubiquinoine biosynthesis in rats | |
| Cholesterol catabolism | |
| Capecitabine and Fluorafur metabolism | |
| ROS in Neutrophil-Mediated Cell Damage | |
| altered retinoid cycle metabolic pathway | |
| insulin secretion pathway | |
| altered insulin secretion pathway | |
| steroid hormone biosynthetic pathway | |
| testosterone biosynthetic pathway | |
| insulin secretion pathway | |
| altered insulin secretion pathway | |
| nicotinamide adenine dinucleotide metabolic pathway |
| Group | Biofluids assayable substances |
|---|
| Source | ChemIDplus |
|---|
| Alias | [4S-(2)H]NADP(H) |
|---|---|
| [4S-(2)H]NAD(P)H | |
| reduced nadide phosphate | |
| reduced Cozymase II | |
| reduced nicotinadenine dinucleotide phosphate | |
| Reduced nicotinamide adenine diphosphate | |
| Reduced triphosphopyridine nucleotide | |
| Triphosphopyridine nucleotide reduced | |
| reduced Coenzyme II | |
| reduced form nicotinamide adenine dinucleotide phosphate | |
| nicotinamide adenine dinucleophosphate reduced form | |
| nadide hydrogen phosphate | |
| beta nadph | |
| nicotine adenine dinucleotide phosphate | |
| nicotineamide-adenine dinucleotide phosphate | |
| NAD[P]H | |
| [4S-(2)H]NADPH | |
| 53-57-6 | |
| dihydrotriphosphopyridine nucleotide reduced | |
| beta reduced nicotinamide adenine dinucleotide phosphate | |
| beta-Nicotinamide-adenine-dinucleotide-phosphorate | |
| b-Nicotinamide-adenine-dinucleotide-phosphorate | |
| Dihydrocodehydrogenase II | |
| dihydronicotinamide adenine dinucleotide-P | |
| reduced Codehydrase II | |
| Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'-5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide | |
| EINECS 200-177-6 | |
| NADP(H) | |
| NADPH | |
| Nicotinamide adenine dinucleotide phosphate | |
| nicotinamide adenine dinucleotide phosphate, reduced form | |
| Nicotinamide-adenine-dinucleotide-phosphorate | |
| Nicotinamide-adenine-dinucleotide-phosphoric acid | |
| Dihydronicotinamide-adenine dinucleotide phosphate | |
| NAD(P)H | |
| nicotinamide adenine dinucleotide phosphate (reduced form) | |
| nicotinamide adenine dinucleotide phosphate reduced | |
| 22046-90-8 | |
| 3545-01-5 |
| KEGG ID | C00005 |
|---|
| MedScan ID | 1081122 |
|---|
| HMDB ID | HMDB00221 |
|---|---|
| HMDB00799 | |
| HMDB06341 |
| CAS ID | 22046-90-8 |
|---|---|
| 3545-01-5 | |
| 53-57-6 |
| PubChem SID | 134971347 |
|---|---|
| 148687 |
| PubChem CID | 5884 |
|---|
| IUPAC Name | [[(2R,3R,4R,5R)-5-adenin-9-yl-3-hydroxy-4-phosphonooxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate |
|---|
| InChIKey | ACFIXJIJDZMPPO-NNYOXOHSSA-N |
|---|
| Rotatable Bond Count | 13 |
|---|
| Molecular Weight | 745.420886 |
|---|---|
| 745.420883 |
| Molecular Formula | C21H30N7O17P3 |
|---|
| XLogP | -6.800000 |
|---|---|
| -6.800000 |
| ChEBI ID | 16474 |
|---|
| Reaxys ID | 77911 |
|---|---|
| 605068 | |
| 1208813 | |
| 1208814 | |
| 1208815 | |
| 1208816 | |
| 1208817 |
| LinkUrl | http://rgd.mcw.edu/rgdweb/ontology/view.html?acc_id=CHEBI:16474 |
|---|
| ChemIDplus ID | 000053576 |
|---|